- Home
- NRG vs ZTS Comparison
NRG vs ZTS Comparison
Compare NRG & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRG | ZTS |
|---|---|---|
| Founded | 1989 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1B | 31.2B |
| IPO Year | 1997 | 2012 |
Fundamental Metrics
Financial Performance| Metric | NRG | ZTS |
|---|---|---|
| Price | $137.63 | $81.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $203.00 | $154.18 |
| AVG Volume (30 Days) | 2.5M | ★ 7.7M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | 1.27% | ★ 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | 0.52 | ★ 1.42 |
| Revenue | ★ $30,713,000,000.00 | $9,467,000,000.00 |
| Revenue This Year | $14.46 | $5.63 |
| Revenue Next Year | $3.12 | $4.77 |
| P/E Ratio | $262.02 | ★ $56.30 |
| Revenue Growth | ★ 9.18 | 2.28 |
| 52 Week Low | $121.22 | $73.82 |
| 52 Week High | $189.96 | $172.23 |
Technical Indicators
Market Signals| Indicator | NRG | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 44.58 | 28.89 |
| Support Level | N/A | $73.82 |
| Resistance Level | $173.02 | $129.32 |
| Average True Range (ATR) | 5.30 | 3.79 |
| MACD | -0.16 | -0.25 |
| Stochastic Oscillator | 42.65 | 18.07 |
Price Performance
Historical ComparisonAbout NRG NRG Energy Inc.
NRG Energy is one of the largest retail energy providers in the US, with 6 million customers. Vivint Smart Home, which NRG acquired in 2023, has 2 million home-services customers. NRG also is one of the largest US independent power producers, with 13 gigawatts of coal, gas, and oil power generation capacity primarily in Texas. The LS Power asset acquisition adds 13 GW of gas-fired power plants mostly in the Eastern US. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.